130714-47-5

Adenosine receptors are potential therapeutic targets for cerebral and cardiac ischaemic diseases, sleep disorders, immune and inflammatory disorders and cancer. N-Cyclohexyl-2''-O-methyladenosine is an inhibitor of adenosine deaminase-induced lipolysis and a selective adenosine A1-R agonist.

Store at -20°C